Cytosorbents Corporation (CTSO) NASDAQ
0.48
+0.0121(+2.59%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.48
+0.0121(+2.59%)
Currency In USD
| Market Cap | 39.78M |
| Enterprise Value | 62.64M |
| P/E Ratio | -2.54 |
| PEG Ratio | 0.38 |
| Price/Sales Ratio | 0.81 |
| Price/Book Ratio | 13.73 |
| Enterprise/Revenue | 1.19 |
| Enterprise/EBITDA | -6.39 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.32 |
| Operating Margin | -0.36 |
| Return On Assets | -0.29 |
| Return On Equity | -1.65 |
| Revenue | 37.06M |
| Revenue/Share | 0.59 |
| Gross Profit | 26.49M |
| EBITDA | -4.36M |
| Net Income | -8.2M |
| Diluted EPS | -0.13 |
| Total Cash | 4.81M |
| Total Cash/Share | 0.08 |
| Total Debt | 18.96M |
| Total Debt/Equity | 8.64 |
| Current Ratio | 1.09 |
| Book Value Per Share | 0.03 |
| 52-Week Change | -44.06 |
| 52-Week High | 1.39 |
| 52-Week Low | 0.44 |
| Moving Average 50 Days | 0.58 |
| Moving Average 200 Days | 0.73 |
| Average Volume | 90,873 |
| Shares Outstanding | 62.79M |
| % Held by Institutions | 26.47 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | December 05, 2014 |